7-(3-hydroxypropyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole | 1195621-89-6

• 分子结构分类: 有机化合物 - 苯类化合物
• 英文名称: 7-(3-hydroxypropyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
• 英文别名: 7-(3'-hydroxypropyl)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole；7-(3-Hydroxypropyl)benzo[c][1,2]oxaborol-1(3h)-ol；3-(1-hydroxy-3H-2,1-benzoxaborol-7-yl)propan-1-ol
• CAS: 1195621-89-6
• 化学式: C₁₀H₁₃BO₃
• 分子量: 192.022
• InChiKey: UQOMTVGUBBKZNF-UHFFFAOYSA-N

物化性质

• 熔点：
  91-93 °C
• 沸点：
  365.3±52.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.17
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-(3-hydroxypropyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 、 sodium methoxide-d3 以 氘代甲醇 为溶剂， 生成
  参考文献：
  名称：

  Convenient and versatile synthesis of formyl-substituted benzoxaboroles

  摘要：

  Despite of the medicinal significance of benzoxaboroles, with the newly discovered clinical compound AN2690 as an example, the synthetic method for rapid diversification of this novel scaffold is lacking. To this end, a versatile and scalable synthesis of formyl-substituted benzoxaboroles is described here. A key step is the mono-oxidation of the two hydroxyls in compound 4 by taking advantage of the stable oxaborole ring in non-coordinating solvents, which was devised based on the study of the intramolecular coordination and exchange properties. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2009.08.026
• 作为产物：
  描述：

  2,6-二甲基溴苯 在 platinum(IV) oxide trihydrate sodium tetrahydroborate 、 potassium permanganate 、 锂硼氢 、 正丁基锂 、 氯化亚砜 、 水 、 氢气 、 silica gel 、 sodium hydride 、 二异丁基氢化铝 、 对甲苯磺酸 、 N,N-二异丙基乙胺 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 甲醇 、 乙醚 、 正己烷 、 二氯甲烷 、 甲苯 、 mineral oil 、 叔丁醇 为溶剂， 反应 53.33h， 生成 7-(3-hydroxypropyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
  参考文献：
  名称：

  [EN] BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS
  [FR] PETITES MOLÉCULES CONTENANT DU BORE EN TANT QU'AGENTS ANTI-PROTOZOAIRES

  摘要：

  这项发明提供了以下公式的新化合物，用于治疗原虫感染，包含这些化合物的药物组合物，以及这些化合物与至少一种额外治疗有效药剂的组合。

  公开号：

  WO2011022337A1

文献信息

• BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS
  申请人：Zhou Huchen

  公开号：US20110207701A1

  公开（公告）日：2011-08-25

  This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.

  该发明提供了用于治疗原虫感染的新化合物，含有这些化合物的制药组合物，以及这些化合物与至少一种额外的治疗有效剂的组合。
• Design, Synthesis, and Structure−Activity Relationship of <i>Trypanosoma brucei</i> Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents
  作者：Dazhong Ding、Qingqing Meng、Guangwei Gao、Yaxue Zhao、Qing Wang、Bakela Nare、Robert Jacobs、Fernando Rock、Michael R. K. Alley、Jacob J. Plattner、Guoqiang Chen、Dawei Li、Huchen Zhou

  DOI：10.1021/jm101225g

  日期：2011.3.10

  African trypanosomiasis, caused by the protozoal pathogen Tlypanosoma brucei (T. brucei), is one of the most neglected tropical diseases that are in great need of new drugs. We report the design and synthesis of T. bruceileucyl-tRNA synthetase (TbLeuRS) inhibitors and their structure activity relationship. Benzoxaborole was used as the core structure and C(6) was modified to achieve improved affinity bared on docking results that showed further binding space at this position. Indeed, compounds with C(7) substitutions showed diminished activity due to clash with the eukaryote specific I4ae helix while substitutions at C(6) gave enhanced affinity. TbLeuRS inhibitors with IC50 as low as 1.6 mu M were discovered, and the structure activity relationship was discussed. The most potent enzyme inhibitors also showed excellent T.brucei parasite growth inhibition activity. This is the first time that TbLeuRS inhibitors are reported, and this study suggests that leucyl-tRNA synthetase (LeuRS) could be a potential target for antiparasitic drug development.
• [EN] BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS<br/>[FR] PETITES MOLÉCULES CONTENANT DU BORE EN TANT QU'AGENTS ANTI-PROTOZOAIRES
  申请人：ANACOR PHARMACEUTICALS INC

  公开号：WO2011022337A1

  公开（公告）日：2011-02-24

  This invention provides novel compounds of the following formula useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.

  这项发明提供了以下公式的新化合物，用于治疗原虫感染，包含这些化合物的药物组合物，以及这些化合物与至少一种额外治疗有效药剂的组合。
• Convenient and versatile synthesis of formyl-substituted benzoxaboroles
  作者：Long Ye、Dazhong Ding、Yiqing Feng、Dongsheng Xie、Puhua Wu、Hui Guo、Qingqing Meng、Huchen Zhou

  DOI：10.1016/j.tet.2009.08.026

  日期：2009.10

  Despite of the medicinal significance of benzoxaboroles, with the newly discovered clinical compound AN2690 as an example, the synthetic method for rapid diversification of this novel scaffold is lacking. To this end, a versatile and scalable synthesis of formyl-substituted benzoxaboroles is described here. A key step is the mono-oxidation of the two hydroxyls in compound 4 by taking advantage of the stable oxaborole ring in non-coordinating solvents, which was devised based on the study of the intramolecular coordination and exchange properties. (C) 2009 Elsevier Ltd. All rights reserved.